Page last updated: 2024-08-24

cephalosporin c and ro-23-9424

cephalosporin c has been researched along with ro-23-9424 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's6 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertasso, A; Georgopapadakou, NH; Pace, J1
Albrecht, HA; Beskid, G; Chan, KK; Christenson, JG; Cleeland, R; Deitcher, KH; Georgopapadakou, NH; Keith, DD; Pruess, DL; Sepinwall, J1
Bertasso, A; Chan, KK; Chapman, JS; Cleeland, R; Cummings, LM; Dix, BA; Georgopapadakou, NH; Keith, DD1
Beskid, G; Chan, K; Cleeland, R; Fallat, V; Keith, DD; Lipschitz, ER; McGarry, DH; Unowsky, J1
Jones, RN; Sanchez, ML1
Appelbaum, PC; Jacobs, MR; Pankuch, GA; Spangler, SK1
Cunningham, B; Nickerson, B; Scypinski, S1
Barreca, GS; Berlinghieri, MC; FocĂ , A; Foti, F; Matera, G1

Other Studies

8 other study(ies) available for cephalosporin c and ro-23-9424

ArticleYear
Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Cell Membrane Permeability; Cephalosporins; Ciprofloxacin; Coliphages; DNA Replication; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Fleroxacin; Fluoroquinolones; Gene Expression Regulation, Bacterial; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin-Binding Proteins; Peptidyl Transferases; Porins

1991
Cephalosporin 3'-quinolone esters with a dual mode of action.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:1

    Topics: Animals; Anti-Infective Agents; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacter; Escherichia coli Infections; Fleroxacin; Fluoroquinolones; Hydrolysis; Mice; Molecular Structure; Pneumococcal Infections; Prodrugs; Quinolones; Rats; Staphylococcus aureus; Structure-Activity Relationship

1990
Mode of action of the dual-action cephalosporin Ro 23-9424.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:7

    Topics: Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Cephalosporins; Ciprofloxacin; DNA Replication; DNA, Bacterial; Enterobacter; Escherichia coli; Fleroxacin; Fluoroquinolones; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus

1989
In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:7

    Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Pseudomonas

1989
Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534.
    Diagnostic microbiology and infectious disease, 1994, Volume: 18, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Ceftazidime; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure

1994
Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31, Issue:2

    Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Culture Media; Fleroxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae

1993
The use of capillary electrophoresis to monitor the stability of a dual-action cephalosporin in solution.
    Journal of pharmaceutical and biomedical analysis, 1995, Volume: 14, Issue:1-2

    Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Drug Stability; Electrophoresis, Capillary; Fleroxacin; Fluoroquinolones; Half-Life; Kinetics; Solutions; Water

1995
Effect of RO 23-9424, cefotaxime and fleroxacin on functions of human polymorphonuclear cells and cytokine production by human monocytes.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:5

    Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Chemotaxis, Leukocyte; Dose-Response Relationship, Drug; Fleroxacin; Fluoroquinolones; Humans; Interleukin-1; Interleukin-8; Lipopolysaccharides; Monocytes; Neutrophils; Phagocytosis; Superoxides; Tumor Necrosis Factor-alpha

1996